Browsing Tag
Wells Fargo
42 posts
MaxLinear (NASDAQ: MXL) slides 22% as AI expectations outrun its Q2 beat
MaxLinear stock fell 22% despite strong Q2 results. Can optical AI growth, rising margins and Q3 guidance justify MXL’s valuation?
Rhythm Pharmaceuticals (RYTM) TRANSCEND trial in NEJM shows 19.8% placebo-adjusted BMI reduction
Rhythm Pharma (RYTM) TRANSCEND Phase 3 published in NEJM validates IMCIVREE for acquired hypothalamic obesity. 10,000-patient US market launch trajectory ahead.
Fiserv (FISV) reportedly exploring $15bn STAR Network sale in Durbin Amendment workaround play
Fiserv in preliminary talks with JPMorgan, Bank of America, Wells Fargo, and PNC on $15 billion STAR Network sale. Read the full analysis.
From launch to constellation: how Rocket Lab’s $8bn Iridium deal closes the loop
Rocket Lab (RKLB) to acquire Iridium (IRDM) in $8B cash-stock deal, creating a vertically integrated space platform. Full analysis from BNT on the SpaceX challenger.
Why Comcast (CMCSA) finally split: inside the NBCUniversal and Sky spinoff
Comcast (CMCSA) splits in two: NBCUniversal and Sky to spin off into a separate public company under Cavanagh; Angelakis returns as Comcast CEO. Read inside.
Rocket Lab (Nasdaq: RKLB) jumps as Iridium deal resets the thesis
Rocket Lab gains Iridium’s recurring satellite revenue, but US$3.6 billion of committed debt turns scarce spectrum into a major leverage test.
Could Rocket Lab’s $8bn Iridium deal redefine its space growth story?
Rocket Lab’s $8 billion Iridium deal could transform RKLB into a vertically integrated space company with launch, satellites, spectrum and recurring services.
RKLB surges, IRDM soars 20% as Rocket Lab strikes $8bn Iridium takeover
Rocket Lab is buying Iridium for $8 billion, pivoting from launch provider to integrated space operator as RKLB, IRDM, PL and ASTS all move. Read the analysis.
Select Medical (NYSE: SEM) shareholders approve $3.9bn buyout as founder-led consortium nears takeover
Select Medical shareholders approve a $3.9bn founder-led buyout. Discover what the deal means for SEM investors, debt and hospital strategy after the vote!
Innodata’s new CFO inherits a booming AI business and a valuation with little room for error
Innodata names Jayant Chauhan CFO as AI growth accelerates. See how finance discipline, M&A expertise and valuation pressure could shape its next phase now.